Report cover image

Artificial Intelligence Markets in IVD

Publisher Kalorama Information
Published Apr 07, 2020
Length 71 Pages
SKU # KLI16208696

Description

Artificial Intelligence Markets in IVD

The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of test data by any medical professional irrespective of expertise. This way AI technology can assist pathologists, laboratorians and clinicians in complex decision-making. This report examines selected AI-based initiatives, collaborations and tests in various in vitro diagnostic (IVD) market segments.

Artificial Intelligence Markets in IVD contains the following important data points:
  • The Market for AI in Diagnostics, 2019
  • Forecasted Market for 2024
  • Breakout of Market by Application, 2019 (Glucose, Histology, Microbiology, Hematology, Biomarker Diagnostic Aids)
  • Breakout of Market by Components, 2019 (Hardware, Software, Services)
  • Significant Partnerships and Initiatives in AI Related to In Vitro Diagnostics
Digital pathology products and diabetes management devices were the first to come to market with data interpretation applications. The last few years have seen the use of AI interpretation apps extended to a broader range of products including microbiology, disease genetics and cancer precision medicine. This report will review some of the AI-linked tests and test services that have come to market and others that are in development in some of the following market segments:
  • Cancer Diagnostics
  • Cardiac Disease Testing
  • Digital Pathology
  • Genetic Testing
  • Glucose Monitoring
  • Hematology
  • Histology
  • Information Technology (including Electronic Medical Records)
  • Liquid Biopsy
  • Microbiology
  • Microbiome
  • Molecular Diagnostics
  • Next-Generation Sequencing
  • Point of Care
  • Transplant Risk Testing
  • Urinalysis
Applications of AI are evolving that predict outcomes such as diagnosis, death or hospital readmission; that improve upon standard risk assessment tools; that elucidate factors that contribute to disease progression; or that advance personalized medicine by predicting a patient’s response to treatment. AI tools are in use and in development to review data and to uncover patterns in the data that can be used to improve analyses and uncover inefficiencies. Many enterprises are joining this effort. The following are among the companies and institutions whose innovations are featured in Artificial Intelligence Markets in IVD:
  • Adaptive Biotechnologies
  • ARUP Laboratories
  • Bay Echo Labs
  • BGI Genomics
  • Biofourmis Singapore Pte. Ltd.
  • CareDX
  • Caris Life Sciences
  • Case Western Reserve University
  • Clever Culture Systems
  • CompCyst
  • Copan Diagnostics
  • Curetis Group
  • Diagnomics
  • DNAnexus
  • Eko
  • Euroclone Diagnostica
  • Flagship Biosciences
  • Freenome
  • Genomenon
  • GenomeSmart
  • Gilead
  • Gnosis Data Analysis
  • Google
  • Grail
  • Ibex Medical
  • IBM Watson Health
  • Individumed
  • Inspirata
  • Institut Curie
  • IntegraGen
  • IQVIA
  • Johns Hopkins
  • LabCorp
  • LungLife AI
  • Maxwell Plus
  • Medtronic
  • Nikon Instruments
  • OPTiM
  • Oxford Nanopore
  • Paragon Genomics
  • PathAI
  • Pathway Genomics
  • Persivia
  • Phase Genomics
  • Philips
  • Predicine
  • PredictImmune
  • Predigraft
  • Qiagen
  • Rady Children’s Institute for Genomic Medicine
  • Reliant Immune Diagnostics
  • RenalytixAI
  • Seegene
  • Siemens Healthineers
  • Sophia Genetics
  • Surgisphere Corporation
  • Sysmex
  • UgenTec
  • Viome
  • Xifin

Table of Contents

71 Pages
    • The Artificial Intelligence Boom
    • The FDA Is Getting Ready
    • COVID-19 and Artificial Intelligence
    • Methodology
    • AI in Clinical Practice
    • Selected AI-based Initiatives / Collaborations / Tests
    • Blood Typing and Screening
    • Cancer
    • Cardiac Disease
    • Genetic Testing
    • Glucose Monitoring
    • Hematology
    • Histology
    • Information Technology
    • Kidney Disease
    • Liquid Biopsy
    • Microbiology
    • Microbiome
    • Molecular Diagnostics
    • Next-Generation Sequencing
    • Parasitology
    • Pathology
    • Point of Care
    • Transplant Risk Testing
    • Urinalysis
    • What the Future Holds
    • Size and Forecast Estimate
    • Market by Application
    • Component Market Analysis

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us